BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans) a medical technology company specializing in ...

IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in implants for orthopedic surgery and the distribution of ...

BORDEAUX, France & BOSTON, December 05, 2024--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company ...

BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Paris:ALIMP) (OTCQX:IMPZY) (Euronext Growth: ALIMP, FR0010458729, PEA-PME eligible; OTCQX: IMPZY), a medical technology company ...

BORDEAUX, France & BOSTON--(BUSINESS WIRE)-- Regulatory News: IMPLANET (Paris:ALIMP) (OTCQX:IMPZY) (Euronext Growth: ALIMP, FR0010458729, PEA-PME eligible; OTCQX: IMPZY), a medical technology company ...

IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, ...

Please provide your email address to receive an email when new articles are posted on . Implanet, a medical technology company specializing in vertebral and knee-surgery implants, recently announced ...

BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible), a medical technology company specializing in vertebral and knee-surgery implants ...

The Spine Implants business generated revenue of €2.11 million in Q1 2025, reflecting an 8% increase compared to the €1.96 million recorded in Q1 2024. The Company also continued to expand its medical ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Implanet announced it has received FDA ...